Airlines Cancel Some Flights Citing Launch of AT&T, Verizon 5G Signals 
 

Some international flights were suspended even as the wireless carriers agreed to limit signals within 2 miles of runways to address air-safety concerns.

 
Peloton Bikes, Treadmills Set to Cost More 
 

The exercise-equipment maker said it is adding hundreds of dollars in setup and delivery charges to the list prices of some of its products.

 
BJ's Wholesale Club to Move Credit Cards to Capital One, a Blow to ADS 
 

The warehouse club sued Alliance Data Systems, saying the card issuer isn't moving fast enough to transfer accounts.

 
Microsoft to Buy Activision Blizzard 
 

After the all-cash deal valued at about $75 billion closes, Activision CEO Bobby Kotick is expected to leave the videogame heavyweight that has been roiled by claims of workplace misconduct.

 
YouTube Shuts Division for Original Programming 
 

The unit launched "Cobra Kai," but most shows never gained traction with viewers.

 
Pfizer's New Covid-19 Pill Works Against Omicron in Lab 
 

The drug's main component worked in three separate laboratory studies, a potentially encouraging sign as the Omicron strain spreads.

 
New York Magazine Union, Management Reach Deal That Will Boost Wages for Staff 
 

The New York Magazine Union says the deal's framework includes salary increases for more than half of staffers and guaranteed yearly increases in pay.

 
Apple Says Senate Tech Bill Would Hurt Its Privacy Push 
 

The iPhone maker said a proposal in Congress would weaken a privacy-protection tool it rolled out last year, adding that the change could benefit "irresponsible" companies profiting from user data.

 
Crypto.com Halts Withdrawals After Suspicious Account Activity 
 

CEO Kris Marszalek said no user funds were lost. The company will offer a full report after it completes an investigation.

 
Gilead Alleges Counterfeiting Ring Sold Its HIV Drugs 
 

The drugmaker said that a network of little-known drug suppliers and distributors sold illicit and potentially dangerous fake versions of its HIV medicines that ended up in pharmacies and in the hands of patients.

(END) Dow Jones Newswires

January 18, 2022 17:15 ET (22:15 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.